Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats

Nutrition. 2019 Jul-Aug:63-64:126-133. doi: 10.1016/j.nut.2019.01.019. Epub 2019 Jan 30.

Abstract

Objectives: Adipose tissue plays a central role in the pathogenesis of insulin resistance (IR) and type 2 diabetes. However, the molecular changes that promote these diseases are not completely understood. Several studies demonstrated that ceramide (Cer) and diacylglycerol (DAG) accumulation in muscle is associated with IR. The aim of this study was to explain whether a high-fat diet (HFD) leads to bioactive lipid accumulation in adipose tissue and how metformin affects the lipid content in adipocytes and the concentration of plasma adipocytokines.

Methods: The experiments were conducted on male Wistar rats divided into three groups: control, HFD-fed, and HFD-fed and treated with metformin. Cer and DAGs were analyzed by liquid chromatography tandem mass spectrometry. Phosphorylation of hormone-sensitive lipase (HSL) was analyzed by Western blot. Oral glucose tolerance and insulin tolerance tests were also performed. Plasma adiponectin and tumor necrosis factor (TNF)-α concentration were measured by enzyme-linked immunosorbent assay.

Results: HFD induced IR and elevated DAGs and Cer content in subcutaneous and visceral adipose tissues, which was accompanied by an increased phosphorylation of HSL. Metformin improved insulin sensitivity, decreased Cer and DAG levels, and attenuated the phosphorylation of HSL in both fat depots. Furthermore, we observed a strong correlation between adiponectin (negative) and TNF-α (positive) and bioactive lipids in both fat tissues.

Conclusions: These results indicated that bioactive lipids accumulation in adipose tissue influences the induction of IR and, at least in part, answered the question of what the insulin-sensitizing effect of metformin at the level of adipose tissue is.

Keywords: Ceramide; DAG; Insulin resistance; Mass spectrometry; Metformin; Subcutaneous adipose tissue; Visceral adipose tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / blood*
  • Adipose Tissue / metabolism*
  • Animals
  • Ceramides / metabolism
  • Diet, High-Fat / adverse effects
  • Diglycerides / metabolism
  • Glucose Tolerance Test
  • Hypoglycemic Agents / pharmacology*
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Lipid Metabolism / drug effects*
  • Male
  • Metformin / pharmacology*
  • Phosphorylation / drug effects
  • Rats
  • Rats, Wistar
  • Sterol Esterase / drug effects

Substances

  • 1,2-diacylglycerol
  • Adipokines
  • Ceramides
  • Diglycerides
  • Hypoglycemic Agents
  • Insulin
  • Metformin
  • Sterol Esterase